161 related articles for article (PubMed ID: 17202350)
1. Regulatory T cells maintain long-term tolerance to myelin basic protein by inducing a novel, dynamic state of T cell tolerance.
Cabbage SE; Huseby ES; Sather BD; Brabb T; Liggitt D; Goverman J
J Immunol; 2007 Jan; 178(2):887-96. PubMed ID: 17202350
[TBL] [Abstract][Full Text] [Related]
2. Endogenous myelin basic protein is presented in the periphery by both dendritic cells and resting B cells with different functional consequences.
Seamons A; Perchellet A; Goverman J
J Immunol; 2006 Aug; 177(4):2097-106. PubMed ID: 16887968
[TBL] [Abstract][Full Text] [Related]
3. In vitro-induced cell-mediated immune deviation to encephalitogenic antigens.
Farooq SM; Ashour HM
Brain Behav Immun; 2014 Jan; 35():64-9. PubMed ID: 24095895
[TBL] [Abstract][Full Text] [Related]
4. Oral tolerance in myelin basic protein T-cell receptor transgenic mice: suppression of autoimmune encephalomyelitis and dose-dependent induction of regulatory cells.
Chen Y; Inobe J; Kuchroo VK; Baron JL; Janeway CA; Weiner HL
Proc Natl Acad Sci U S A; 1996 Jan; 93(1):388-91. PubMed ID: 8552644
[TBL] [Abstract][Full Text] [Related]
5. Myelin-reactive, TGF-β-induced regulatory T cells can be programmed to develop Th1-like effector function but remain less proinflammatory than myelin-reactive Th1 effectors and can suppress pathogenic T cell clonal expansion in vivo.
O'Connor RA; Leech MD; Suffner J; Hämmerling GJ; Anderton SM
J Immunol; 2010 Dec; 185(12):7235-43. PubMed ID: 21084662
[TBL] [Abstract][Full Text] [Related]
6. Age-dependent T cell tolerance and autoimmunity to myelin basic protein.
Huseby ES; Sather B; Huseby PG; Goverman J
Immunity; 2001 Apr; 14(4):471-81. PubMed ID: 11336692
[TBL] [Abstract][Full Text] [Related]
7. IL-4 is a differentiation factor for transforming growth factor-beta secreting Th3 cells and oral administration of IL-4 enhances oral tolerance in experimental allergic encephalomyelitis.
Inobe J; Slavin AJ; Komagata Y; Chen Y; Liu L; Weiner HL
Eur J Immunol; 1998 Sep; 28(9):2780-90. PubMed ID: 9754565
[TBL] [Abstract][Full Text] [Related]
8. The in vivo and in vitro induction of anterior chamber associated immune deviation to myelin antigens in C57BL/6 mice.
Farooq SM; Elkhatib WF; Ashour HM
Brain Behav Immun; 2014 Nov; 42():118-22. PubMed ID: 24953428
[TBL] [Abstract][Full Text] [Related]
9. Cutting edge: in vitro-generated tolerogenic APC induce CD8+ T regulatory cells that can suppress ongoing experimental autoimmune encephalomyelitis.
Faunce DE; Terajewicz A; Stein-Streilein J
J Immunol; 2004 Feb; 172(4):1991-5. PubMed ID: 14764660
[TBL] [Abstract][Full Text] [Related]
10. Adoptive transfer of myelin basic protein-tolerized splenocytes to naive animals reduces infarct size: a role for lymphocytes in ischemic brain injury?
Becker K; Kindrick D; McCarron R; Hallenbeck J; Winn R
Stroke; 2003 Jul; 34(7):1809-15. PubMed ID: 12791945
[TBL] [Abstract][Full Text] [Related]
11. Antigen-oriented T cell migration contributes to myelin peptide induced-EAE and immune tolerance.
Zheng P; Fu H; Wei G; Wei Z; Zhang J; Ma X; Rui D; Meng X; Ming L
Clin Immunol; 2016 Aug; 169():36-46. PubMed ID: 27327113
[TBL] [Abstract][Full Text] [Related]
12. The thymus plays a role in oral tolerance in experimental autoimmune encephalomyelitis.
Song F; Guan Z; Gienapp IE; Shawler T; Benson J; Whitacre CC
J Immunol; 2006 Aug; 177(3):1500-9. PubMed ID: 16849456
[TBL] [Abstract][Full Text] [Related]
13. Immune regulatory effects of central nervous system antigens in culture.
Lindsey JW; Jin R
Int Immunol; 2000 Nov; 12(11):1605-12. PubMed ID: 11058580
[TBL] [Abstract][Full Text] [Related]
14. Viral infection triggers central nervous system autoimmunity via activation of CD8+ T cells expressing dual TCRs.
Ji Q; Perchellet A; Goverman JM
Nat Immunol; 2010 Jul; 11(7):628-34. PubMed ID: 20526343
[TBL] [Abstract][Full Text] [Related]
15. Induction of circulating myelin basic protein and proteolipid protein-specific transforming growth factor-beta1-secreting Th3 T cells by oral administration of myelin in multiple sclerosis patients.
Fukaura H; Kent SC; Pietrusewicz MJ; Khoury SJ; Weiner HL; Hafler DA
J Clin Invest; 1996 Jul; 98(1):70-7. PubMed ID: 8690806
[TBL] [Abstract][Full Text] [Related]
16. In situ tolerance within the central nervous system as a mechanism for preventing autoimmunity.
Brabb T; von Dassow P; Ordonez N; Schnabel B; Duke B; Goverman J
J Exp Med; 2000 Sep; 192(6):871-80. PubMed ID: 10993917
[TBL] [Abstract][Full Text] [Related]
17. Differential effects of myelin basic protein-activated Th1 and Th2 cells on the local immune microenvironment of injured spinal cord.
Hu JG; Shi LL; Chen YJ; Xie XM; Zhang N; Zhu AY; Jiang ZS; Feng YF; Zhang C; Xi J; Lü HZ
Exp Neurol; 2016 Mar; 277():190-201. PubMed ID: 26772636
[TBL] [Abstract][Full Text] [Related]
18. Oral tolerance to copolymer 1 in myelin basic protein (MBP) TCR transgenic mice: cross-reactivity with MBP-specific TCR and differential induction of anti-inflammatory cytokines.
Maron R; Slavin AJ; Hoffmann E; Komagata Y; Weiner HL
Int Immunol; 2002 Feb; 14(2):131-8. PubMed ID: 11809732
[TBL] [Abstract][Full Text] [Related]
19. Induction of immunologic tolerance to myelin basic protein prevents central nervous system autoimmunity and improves outcome after stroke.
Gee JM; Kalil A; Thullbery M; Becker KJ
Stroke; 2008 May; 39(5):1575-82. PubMed ID: 18323496
[TBL] [Abstract][Full Text] [Related]
20. Negative feedback control of the autoimmune response through antigen-induced differentiation of IL-10-secreting Th1 cells.
Gabrysová L; Nicolson KS; Streeter HB; Verhagen J; Sabatos-Peyton CA; Morgan DJ; Wraith DC
J Exp Med; 2009 Aug; 206(8):1755-67. PubMed ID: 19635862
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]